These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29476931)

  • 1. Vitamin D receptor (VDR) non-synonymous single nucleotide polymorphisms (nsSNPs) affect the calcitriol drug response - A theoretical insight.
    Muthusamy K; Nagamani S
    J Mol Graph Model; 2018 May; 81():14-24. PubMed ID: 29476931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating in silico prediction methods, molecular docking, and molecular dynamics simulation to predict the impact of ALK missense mutations in structural perspective.
    Doss CG; Chakraborty C; Chen L; Zhu H
    Biomed Res Int; 2014; 2014():895831. PubMed ID: 25054154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional insights on vitamin D receptor and CYP24A1 deleterious single nucleotide polymorphisms: A computational and pharmacogenomics perpetual approach.
    Jayaraj JM; Kuriakose BB; Alhazmi AH; Muthusamy K
    Cell Biochem Funct; 2021 Oct; 39(7):874-885. PubMed ID: 34231237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.
    Rochel N; Hourai S; Pérez-García X; Rumbo A; Mourino A; Moras D
    Arch Biochem Biophys; 2007 Apr; 460(2):172-6. PubMed ID: 17346665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
    Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
    Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific interactions between vitamin-D receptor and its ligands: Ab initio molecular orbital calculations in water.
    Takeda R; Kobayashi I; Shimamura K; Ishimura H; Kadoya R; Kawai K; Kittaka A; Takimoto-Kamimura M; Kurita N
    J Steroid Biochem Mol Biol; 2017 Jul; 171():75-79. PubMed ID: 28242261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of hereditary vitamin D-resistant rickets--associated mutant H305Q of vitamin D nuclear receptor bound to its natural ligand.
    Rochel N; Hourai S; Moras D
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):84-7. PubMed ID: 20403435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain.
    Yamamoto K; Masuno H; Choi M; Nakashima K; Taga T; Ooizumi H; Umesono K; Sicinska W; VanHooke J; DeLuca HF; Yamada S
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1467-72. PubMed ID: 10677485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the vitamin D receptor by vitamin D lactam derivatives.
    Asano L; Waku T; Abe R; Kuwabara N; Ito I; Yanagisawa J; Nagasawa K; Shimizu T
    FEBS Lett; 2016 Sep; 590(18):3270-9. PubMed ID: 27500498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two mutations causing vitamin D resistant rickets: modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures.
    Rut AR; Hewison M; Kristjansson K; Luisi B; Hughes MR; O'Riordan JL
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):581-90. PubMed ID: 7828346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function.
    Malloy PJ; Xu R; Peng L; Peleg S; Al-Ashwal A; Feldman D
    Endocrinology; 2004 Nov; 145(11):5106-14. PubMed ID: 15308610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal of novel inhibitors for vitamin-D receptor: Molecular docking, molecular mechanics and ab initio molecular orbital simulations.
    Nakamura S; Saito R; Yamamoto S; Terauchi Y; Kittaka A; Takimoto-Kamimura M; Kurita N
    Biophys Chem; 2021 Mar; 270():106540. PubMed ID: 33418104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-based pharmacophore modeling and docking studies on vitamin D receptor inhibitors.
    Yadav DK; Kumar S; Teli MK; Kim MH
    J Cell Biochem; 2020 Jul; 121(7):3570-3583. PubMed ID: 31904142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach.
    George Priya Doss C; Nagasundaram N; Chakraborty C; Chen L; Zhu H
    Hum Genomics; 2013 Apr; 7(1):10. PubMed ID: 23561625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between 1alpha,25(OH)2D3 and residues in the ligand-binding pocket of the vitamin D receptor: a correlated fragment molecular orbital study.
    Yamagishi K; Tokiwa H; Makishima M; Yamada S
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):63-7. PubMed ID: 20236613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand recognition by the vitamin D receptor.
    Choi M; Yamamoto K; Masuno H; Nakashima K; Taga T; Yamada S
    Bioorg Med Chem; 2001 Jul; 9(7):1721-30. PubMed ID: 11425573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
    Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor.
    Gonzalez MM; Samenfeld P; Peräkylä M; Carlberg C
    Mol Endocrinol; 2003 Oct; 17(10):2028-38. PubMed ID: 12843209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A theoretical insight to understand the molecular mechanism of dual target ligand CTA-018 in the chronic kidney disease pathogenesis.
    Nagamani S; Muthusamy K
    PLoS One; 2018; 13(10):e0203194. PubMed ID: 30286109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.